feed,title,long_url,short_url
MedRxiv,"A randomized, double-blind, Phase 1 study of IN-006, an inhaled antibody treatment for COVID-19",https://medrxiv.org/cgi/content/short/2022.08.17.22278748v1?rss=1,https://bit.ly/3T4JL4y
